Clinical trial
Longitudinal Study of Neurodegenerative Disorders
NCT03333200 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Longitudinal Study of Neurodegenerative Disorders
- Lead sponsor
- University of Pittsburgh
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 11, 2012
- Completion date
- January 31, 2035
- Enrollment
- 1,500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ald, alpha-mannosidosis, batten disease, gan, gaucher disease, gm1 gangliosidoses, gm3 gangliosidosis, krabbe disease, leukodystrophy, lysosomal storage diseases, mld, morquio disease, mps i, mps ii, mps iii, mps iv, multiple sulfatase deficiency disease, niemann-pick diseases, np deficiency, osteopetrosis, pelizaeus-merzbacher disease, pkan, purine nucleoside phosphorylase deficiency, s-adenosylhomocysteine hydrolase deficiency, sandhoff disease, tay-sachs disease, vanishing white matter disease